Brinzolamide

Results: 11



#Item
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZOPT® safely and effectively. See full prescribing information for AZOPT®.  ----------------WARNINGS AND PRECAUTI

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZOPT® safely and effectively. See full prescribing information for AZOPT®. ----------------WARNINGS AND PRECAUTI

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2016-04-27 08:32:10
2HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMBRINZA® safely and effectively. See full prescribing information for SIMBRINZA SIMBRINZA (brinzolamide/brimonidi

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMBRINZA® safely and effectively. See full prescribing information for SIMBRINZA SIMBRINZA (brinzolamide/brimonidi

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2016-04-27 08:32:13
3Contains Nonbinding Recommendations  Draft Guidance on Dorzolamide Hydrochloride This draft guidance, once finalized, will represent the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does

Contains Nonbinding Recommendations Draft Guidance on Dorzolamide Hydrochloride This draft guidance, once finalized, will represent the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does

Add to Reading List

Source URL: www.fda.gov

Language: English
4Lyceum Chinense and Calcium Phosphate Nanoparticles for Ophthalmic Drug Delivery Q. He1, 2, Zhenqing Fang2, M. Wang2, Q.W. Xu2, R Chen2, D. Li2, X.Z.Zhang1, W.M. Yaun1, D.M Zhau1, Jian Wu3 1 Nanjing Carrier Nano-Biotech

Lyceum Chinense and Calcium Phosphate Nanoparticles for Ophthalmic Drug Delivery Q. He1, 2, Zhenqing Fang2, M. Wang2, Q.W. Xu2, R Chen2, D. Li2, X.Z.Zhang1, W.M. Yaun1, D.M Zhau1, Jian Wu3 1 Nanjing Carrier Nano-Biotech

Add to Reading List

Source URL: www.nsti.org

Language: English - Date: 2013-11-18 16:22:19
5HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZOPT® safely and effectively. See full prescribing information for AZOPT®.  ----------------WARNINGS AND PRECAUTI

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZOPT® safely and effectively. See full prescribing information for AZOPT®. ----------------WARNINGS AND PRECAUTI

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2014-05-06 21:38:29
6Microsoft Word - Ophthalmics Glaucoma Oct 09.doc

Microsoft Word - Ophthalmics Glaucoma Oct 09.doc

Add to Reading List

Source URL: www.oregon.gov

Language: English - Date: 2014-07-15 14:00:36
7Newsletter May 2014 final

Newsletter May 2014 final

Add to Reading List

Source URL: lgdata.s3-website-us-east-1.amazonaws.com

Language: English - Date: 2014-06-25 12:59:42
8200890_pilocarpine_Clinical_PREA

200890_pilocarpine_Clinical_PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
9Executive Summary   Application Type Submission Number Submission Code

Executive Summary Application Type Submission Number Submission Code

Add to Reading List

Source URL: www.fda.gov

Language: English
10Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery

Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English